Recent Advances in Marine Origin Compound-Based Formulation with Anti-inflammatory Properties
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 2397
Special Issue Editors
Interests: brown algae; extraction; natural deep eutectic solvents; fucoidan; polyphenols; alginic acid; laminaran; phloroglucinol; mannitol; fucoxanthin; drug delivery system; bioavailability; HPLC
Special Issues, Collections and Topics in MDPI journals
Interests: algae; controlled release; extraction; green solvents; hydrobionts; fucoidan; mechanisms of action; polyphenols; pharmacokinetics; analysis
Special Issue Information
Dear Colleagues,
Compounds from marine organisms of various taxa form a pool of molecules that are unique in structure and properties and have enormous medicinal potential. Recent years have been marked by the discovery of new compounds of marine origin and the study of their pharmacological activity. Marine organisms produce active compounds of various groups, including polysaccharides, polyphenols, pigments, sterols, vitamins, and others.
An effective and non-toxic anti-inflammatory agent is one of the key problems of modern science. Non-steroidal anti-inflammatory drugs and glucocorticoids are currently considered the most effective; however, a wide range of side effects affecting almost all organs and tissues of the body limit their long-term use. This special issue will focus on research papers, reviews, brief reports and prospects for the use of new marine compounds-based formulations with anti-inflammatory effects, in favor of new research, with clear and proven effects and industrial applications and focus.
Dr. Ekaterina D. Obluchinskaya
Dr. Olga N. Pozharitskaya
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- allodynia
- anti-inflammatory
- cytokine storm
- extraction
- formulation
- fractionation
- hyperalgesia
- interleukins
- kinases
- mechanisms of action
- polysaccharides
- polyphenols
- sterols
- lipids
- pigment
- prostaglandins
- purification
- synergy
